Literature DB >> 20194888

Role of ticagrelor in clopidogrel nonresponders: resistance is futile?

Luke Tapp, Eduard Shantsila, Gregory Y H Lip.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194888     DOI: 10.1161/CIR.0b013e3181d8d929

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  Ticagrelor: a review of its use in the management of acute coronary syndromes.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

Review 2.  Impact of genetic polymorphisms on platelet function and response to anti platelet drugs.

Authors:  Teresa Strisciuglio; Danilo Franco; Giuseppe Di Gioia; Chiara De Biase; Carmine Morisco; Bruno Trimarco; Emanuele Barbato
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

3.  Clinical pharmacodynamics and long-term efficacy of Talcom vs. Plavix in patients undergoing coronary stent implantation: a randomized study with 5-year follow-up.

Authors:  Jinshuang Li; Yuansheng Fan; Tiantian Zhu; Jun Chen; Deyu Kong; Haoyu Meng; Jing Zhang; Ke Xu; Sen Ye; Yuqin Ji; Chunjian Li
Journal:  Eur J Clin Pharmacol       Date:  2018-08-20       Impact factor: 2.953

4.  The use of cangrelor in neurovascular interventions: a multicenter experience.

Authors:  Gustavo M Cortez; André Monteiro; Nader Sourour; Frédéric Clarençon; Mahmoud Elhorany; Mikayel Grigoryan; Soz Mirza; Guilherme Dabus; Italo Linfante; Pedro Aguilar-Salinas; Yasmeen Murtaza; Amin Aghaebrahim; Eric Sauvageau; Ricardo A Hanel
Journal:  Neuroradiology       Date:  2020-11-11       Impact factor: 2.804

5.  Ticagrelor (brilinta), an antiplatelet drug for acute coronary syndrome.

Authors:  Raeanne Fuller; Benjamin Chavez
Journal:  P T       Date:  2012-10

6.  Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor.

Authors:  Kade Birkeland; David Parra; Robert Rosenstein
Journal:  J Blood Med       Date:  2010-09-01

7.  Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Authors:  Jianan Li; Hong Qiu; Lirong Yan; Tingting Guo; Yong Wang; Yang Li; Jianfeng Zheng; Yida Tang; Bo Xu; Shubin Qiao; Yuejin Yang; Runlin Gao
Journal:  J Atheroscler Thromb       Date:  2020-09-08       Impact factor: 4.928

8.  Do Clopidogrel Nonresponders Have an Increased Risk of Adverse Events during Supra-Aortal Angioplasty and Stenting?

Authors:  Heiko Koerner; Christian Derveaux; Maria Alexandrou; Stefan Graeber; Christian Roth; Panagiotis Papanagiotou; Hermann Eichler; Wolfgang Reith
Journal:  Stroke Res Treat       Date:  2012-02-28

9.  Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin.

Authors:  Hamzah Khan; Reid Gallant; Shubha Jain; Mohammed Al-Omran; Charles De Mestral; Elisa Greco; Mark Wheatcroft; Ashraf Alazonni; Rawand Abdin; Margaret L Rand; Heyu Ni; Mohammad Qadura
Journal:  Medicina (Kaunas)       Date:  2020-10-02       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.